Maintaining the exchange of critical health data – An adequacy decision on the UK data protection regime

New report assesses progress on biosimilar medicine policies… 29 March 2021 Biosimilar medicines are increasingly relevant to public health as emphasised by the…
HERA must address outstanding weaknesses in EU pharma… 16 September 2021 Medicines For Europe strongly supports the EU’s drive to learn from COVID-19…
European Commission pilot project on repurposing brings… 28 October 2021 Innovation on existing, well-known molecules through repurposing can deliver huge benefits for patients and address unmet medical needs sustainably. Today…
Adjustments to IP framework needed to improve access to… 16 November 2021 Access to generic and biosimilar medicines can be improved with coherent proposals for IP…